Immunotherapy in chronic myelogenous leukemia. (Record no. 16936520)

MARC details
000 -LEADER
fixed length control field 01442 a2200409 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250515062247.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 200705s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 1557-9190
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.3816/clm.2007.s.004
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Guilhot, François
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20070501
245 00 - TITLE STATEMENT
Title Immunotherapy in chronic myelogenous leukemia.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Clinical lymphoma & myeloma
Date of publication, distribution, etc. Mar 2007
300 ## - PHYSICAL DESCRIPTION
Extent S64-70 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Journal Article; Review
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Benzamides
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Clinical Trials as Topic
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Heat-Shock Proteins
General subdivision immunology
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Hematopoietic Stem Cell Transplantation
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Imatinib Mesylate
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Immunotherapy
General subdivision methods
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Immunotherapy, Adoptive
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Interferons
General subdivision therapeutic use
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Leukemia, Myelogenous, Chronic, BCR-ABL Positive
General subdivision therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Piperazines
General subdivision therapeutic use
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Pyrimidines
General subdivision therapeutic use
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element T-Lymphocytes, Cytotoxic
General subdivision immunology
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Transplantation, Homologous
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Roy, Lydia
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Martineua, Geraldine
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Guilhot, Joëlle
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Millot, Frederic
773 0# - HOST ITEM ENTRY
Title Clinical lymphoma & myeloma
Related parts vol. 7 Suppl 2
-- p. S64-70
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.3816/clm.2007.s.004">https://doi.org/10.3816/clm.2007.s.004</a>
Public note Available from publisher's website

No items available.